$Standard BioTools (LAB.US)$ 10% Shareholder Casdin Partners Master Fund, L.P. purchased 100K shares of common stock on May 23, 2024 at an average price of $2.6 for a total value of $260K.
This transaction involves other related parties: Casdin Eli, Casdin Capital, LLC, Casdin Partners GP, LLC, Casdin Private Growth Equity Fund II, L.P., Casdin Private Growth Equity Fund II GP, LLC, Casdin Private Growth Equity Fund, L.P., CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC and Casdin Partners FO1-MSV, LP.
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.